Baron Silver Stevens Financial Advisors, LLC Teva Pharmaceutical Industries LTD Transaction History

Baron Silver Stevens Financial Advisors, LLC

$569 Million
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	BUY	$6.86 - $11.95 $6,860 - $11,950	1,000 New	1,000 $254,000
Q1 2021 Apr 27, 2021	SELL	$10.34 - $12.81 $10,340 - $12,810	-1,000 Closed	0 $0
Q4 2020 Mar 19, 2021	BUY	$8.61 - $11.04 $8,610 - $11,040	1,000 New	1,000 $9,000

Others Institutions Holding TEVA

# of Institutions

625

Shares Held

573M

Call Options Held

19.6M

Put Options Held

6.77M

Black Rock Inc. New York, NY

43M
Shares

$979 Million
0.02% of portfolio
Ion Asset Management Ltd. George Town, Grand Cayman, E9

36.2M
Shares

$825 Million
35.87% of portfolio
Clal Insurance Enterprises Holdings LTD Tel Aviv, L3

34.5M
Shares

$787 Million
5.5% of portfolio
Menora Mivtachim Holdings Ltd.

28.8M
Shares

$657 Million
3.32% of portfolio
Exor Capital LLP London, X0

26.5M
Shares

$603 Million
14.79% of portfolio

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $25.3B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baron Silver Stevens Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baron Silver Stevens Financial Advisors, LLC with notifications on news.

Account